Enhancing the QUAlity and Transparency Of health Research

EQUATOR resources in German | Portuguese | Spanish

Blog Archives

11/01/2018 Methodology of assessment and reporting of safety in anti-malarial treatment efficacy studies of uncomplicated falciparum malaria in pregnancy: a systematic literature review 18/10/2016 Eliciting the child’s voice in adverse event reporting in oncology trials: Cognitive interview findings from the Pediatric Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events initiative 11/10/2016 Recommendations to improve adverse event reporting in clinical trial publications: a joint pharmaceutical industry/journal editor perspective 22/03/2016 Definition and classification of intraoperative complications (CLASSIC): Delphi study and pilot evaluation 10/02/2016 PRISMA harms checklist: improving harms reporting in systematic reviews 11/02/2015 Viscerotropic disease: case definition and guidelines for collection, analysis, and presentation of immunization safety data 04/02/2015 Diarrhea: case definition and guidelines for collection, analysis, and presentation of immunization safety data 04/02/2015 Immunization site pain: case definition and guidelines for collection, analysis, and presentation of immunization safety data 04/02/2015 Can the Brighton Collaboration case definitions be used to improve the quality of Adverse Event Following Immunization (AEFI) reporting? Anaphylaxis as a case study 30/09/2013 Better reporting of harms in randomized trials: an extension of the CONSORT Statement

Blog archives

Latest guest blogger

  • Why did we develop TIDieR-Placebo?

    The TIDieR reporting guideline helps authors fully report their interventions, so that they can be used by others. However, TIDieR only explicitly covers active interventions, not placebo controls. The developers of the new TIDieR-Placebo extension explain why it is needed Read More